Genetic and functional studies have highlighted the relevance of perturbed synaptic plasticity in psychiatric disorders [12, 27, 44, 45, 74–76], although we find that the risk conferred by variants affecting such pathways overrepresented among FMRP targets is concentrated within the fraction of genes targeted by FMRP. This evidence concerns the gene FMR1 and psychiatric disorder.